TMCnet News

Research and Markets: Hepatic (Liver) Tumor Pipeline Insights Report 2015
[January 29, 2015]

Research and Markets: Hepatic (Liver) Tumor Pipeline Insights Report 2015


Research and Markets (http://www.researchandmarkets.com/research/dhkjgr/hepatic_liver) has announced the addition of the "Hepatic (Liver) Tumor-Pipeline Insights, 2015" subscription to their offering.

This Hepatic Liver Tumor-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Hepatic Liver Tumor.

This report provides information on the therapeutic development based on the Hepatic Liver Tumor dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinicl, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.



The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:


  1. Hepatic Liver Tumor Overview
  2. Hepatic Liver Tumor Pipeline Therapeutics
  3. Hepatic Liver Tumor Therapeutics under Development by Companies
  4. Hepatic Liver Tumor Late Stage Products (Filed and Phase III)
  5. Comparative Analysis
  6. Hepatic Liver Tumor Mid Clinical Stage Products (Phase II)
  7. Comparative Analysis
  8. Hepatic Liver Tumor Early Clinical Stage Products (Phase I and IND Filed)
  9. Comparative Analysis
  10. Hepatic Liver Tumor Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Hepatic Liver Tumor - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Hepatic Liver Tumor - Discontinued Products
  19. Hepatic Liver Tumor - Dormant Products
  20. Companies Involved in Therapeutics Development for Hepatic Liver Tumor
  21. Appendix

For more information visit http://www.researchandmarkets.com/research/dhkjgr/hepatic_liver


[ Back To TMCnet.com's Homepage ]